Detalles de la búsqueda
1.
Twice-Daily Dolutegravir Based Antiretroviral Therapy with One Month of Daily Rifapentine and Isoniazid (1HP) for TB Prevention.
Clin Infect Dis
; 2024 Apr 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38568956
2.
Pharmacokinetics and Pharmacodynamics of Depot Medroxyprogesterone Acetate in African Women Receiving Treatment for Human Immunodeficiency Virus and Tuberculosis: Potential Concern for Standard Dosing Frequency.
Clin Infect Dis
; 71(3): 517-524, 2020 07 27.
Artículo
en Inglés
| MEDLINE | ID: mdl-31504342
3.
Pharmacogenetic interactions between antiretroviral drugs and vaginally administered hormonal contraceptives.
Pharmacogenet Genomics
; 30(3): 45-53, 2020 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-32106141
4.
Raltegravir pharmacokinetics before and during treatment with ombitasvir, paritaprevir/ritonavir plus dasabuvir in adults with human immunodeficiency virus-1 and hepatitis C virus coinfection: AIDS Clinical Trials Group sub-study A5334s.
Br J Clin Pharmacol
; 86(1): 132-142, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31656054
5.
Depot medroxyprogesterone acetate in combination with a twice-daily lopinavir-ritonavir-based regimen in HIV-infected women showed effective contraception and a lack of clinically significant interactions, with good safety and tolerability: results of the ACTG 5283 study.
Antimicrob Agents Chemother
; 59(4): 2094-101, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25624326
6.
Novel dosing strategies increase exposures of the potent antituberculosis drug rifapentine but are poorly tolerated in healthy volunteers.
Antimicrob Agents Chemother
; 59(6): 3399-405, 2015.
Artículo
en Inglés
| MEDLINE | ID: mdl-25824215
7.
Phase I safety, pharmacokinetics, and pharmacogenetics study of the antituberculosis drug PA-824 with concomitant lopinavir-ritonavir, efavirenz, or rifampin.
Antimicrob Agents Chemother
; 58(9): 5245-52, 2014 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24957823
8.
Assessing Prolongation of the Corrected QT Interval with Bedaquiline and Delamanid Coadministration to Predict the Cardiac Safety of Simplified Dosing Regimens.
Clin Pharmacol Ther
; 112(4): 873-881, 2022 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35687528
9.
Safety, tolerability, and mechanisms of antiretroviral activity of pegylated interferon Alfa-2a in HIV-1-monoinfected participants: a phase II clinical trial.
J Infect Dis
; 201(11): 1686-96, 2010 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-20420510
10.
QT effects of bedaquiline, delamanid, or both in patients with rifampicin-resistant tuberculosis: a phase 2, open-label, randomised, controlled trial.
Lancet Infect Dis
; 21(7): 975-983, 2021 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33587897
11.
Antiretroviral Activity of AMD11070 (An Orally Administered CXCR4 Entry Inhibitor): Results of NIH/NIAID AIDS Clinical Trials Group Protocol A5210.
AIDS Res Hum Retroviruses
; 35(8): 691-697, 2019 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-31099252
12.
Antiretroviral therapy and vaginally administered contraceptive hormones: a three-arm, pharmacokinetic study.
Lancet HIV
; 6(9): e601-e612, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31498109
13.
Effect of hydroxyurea and dideoxyinosine on intracellular 3'-deoxyadenosine-5'-triphosphate concentrations in HIV-infected patients.
AIDS Res Hum Retroviruses
; 23(11): 1360-5, 2007 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-18184078
14.
Effect of Depot Medoxyprogesterone Acetate on Immune Functions and Inflammatory Markers of HIV-Infected Women.
J Acquir Immune Defic Syndr
; 71(2): 137-45, 2016 Feb 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26413850
15.
Safety, tolerability, and pharmacokinetic interactions of the antituberculous agent TMC207 (bedaquiline) with efavirenz in healthy volunteers: AIDS Clinical Trials Group Study A5267.
J Acquir Immune Defic Syndr
; 59(5): 455-62, 2012 Apr 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-22126739
16.
Sex differences in lopinavir and ritonavir pharmacokinetics among HIV-infected women and men.
J Clin Pharmacol
; 51(12): 1665-73, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21233301
17.
The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis.
AIDS
; 22(15): 1919-27, 2008 Oct 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-18784455
18.
Hemodialysis does not significantly affect the pharmacokinetics of nevirapine in HIV-1-infected persons requiring hemodialysis: results from ACTG A5177.
J Acquir Immune Defic Syndr
; 54(4): e7-9, 2010 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-20611034
Resultados
1 -
18
de 18
1
Próxima >
>>